These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10919345)

  • 1. Anosmia induced with alpha interferon in a patient with chronic hepatitis C.
    Kraus I; Vitezic D
    Int J Clin Pharmacol Ther; 2000 Jul; 38(7):360-1. PubMed ID: 10919345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [IFN-induced anosmia y ageusia in chronic hepatitis C].
    Manzano Alonso ML; Muñoz Gómez R; Castellano Tortajada G; Solis Herruzo JA
    Gastroenterol Hepatol; 2001 Oct; 24(8):412. PubMed ID: 11674965
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anosmia secondary to treatment with interferon in a patient with chronic hepatitis C].
    Fernández Fernández FJ; Castiella Eguzkiza A; Tejada Calabia AM; García Bengoechea M
    Gastroenterol Hepatol; 2000 Dec; 23(10):499-500. PubMed ID: 11149229
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon-induced anosmia in a patient with chronic hepatitis C.
    Maruyama S; Hirayama C; Kadowaki Y; Sagayama A; Omura H; Nakamoto M
    Am J Gastroenterol; 1998 Jan; 93(1):122-3. PubMed ID: 9448193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative results of therapy with amizon and reaferon of patients with chronic viral hepatitis B and C and kidney complications].
    Kominko LV
    Lik Sprava; 2003; (2):81-4. PubMed ID: 12774484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune thrombocytopenic purpura in a patient treated with interferon alfacon-1.
    Dimitroulopoulos D; Dourakis SP; Xinopoulos D; Tsamakidis K; Paraskevas E
    J Viral Hepat; 2004 Sep; 11(5):477-8. PubMed ID: 15357656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis.
    Schäfer M; Schmidt F; Amann B; Schlösser S; Loeschke K; Grunze H
    Neuropsychobiology; 2000; 42 Suppl 1():43-5. PubMed ID: 11093071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction therapy in chronic hepatitis C: déjà-vu with pegylated interferons?
    Zeuzem S
    J Hepatol; 2004 Sep; 41(3):488-90. PubMed ID: 15336454
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha.
    Malaguarnera M; Di Fazio I; Restuccia S; Pistone G; Ferlito L; Rampello L
    Neuropsychobiology; 1998; 37(2):93-7. PubMed ID: 9566274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary study of the efficacy of 12 weeks treatment with consensus-interferon in patients with chronic hepatitis C infected with serogroup 2 and low pretreatment viremia].
    Okuse C; Michihiro S; Yoshihiko N; Hiroki I; Hideaki T; Hiroshi Y; Shiro I; Fumio I
    Nihon Shokakibyo Gakkai Zasshi; 2007 Feb; 104(2):245-6. PubMed ID: 17283421
    [No Abstract]   [Full Text] [Related]  

  • 11. Pneumococcal meningitis during antiviral treatment with interferon and ribavirin in a splenectomized patient with chronic hepatitis C - do not miss vaccination before starting therapy.
    Hadem J; Cornberg M; Hauptmann C; Süttmann U; Manns MP; Wedemeyer H
    Z Gastroenterol; 2008 Sep; 46(9):880-2. PubMed ID: 18810674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Consensus and peg-interferon in chronic hepatitis C. Therapy for refractory cases?].
    Kaiser S
    MMW Fortschr Med; 2001 Apr; 143(16):36-7. PubMed ID: 11367991
    [No Abstract]   [Full Text] [Related]  

  • 13. [Observation on the efficacy and safety of Infergen combined with capsule ribavirin in treatment of hepatitis C patients].
    Luo GH; Liao BM; Huang SB
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):363. PubMed ID: 15225435
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiotoxic properties of interferon: aggravation of atrio-ventricular block during treatment of chronic hepatitis C with peginterferon--a case report].
    Rechciński T; Matusik D; Rudziński T; Bednarkiewicz Z; Paprotna K; Deroń Z; Kurpesa M; Krzemińska-Pakuła M
    Pol Arch Med Wewn; 2007; 117(1-2):49-52. PubMed ID: 17642207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C with high viral load of serum hepatitis C virus RNA, genotype 1b, discontinued on attaining sustained virological response at week 16 after onset of acute pancreatitis.
    Kim SR; Imoto S; Mita K; Taniguchi M; Sasase N; Muramatsu A; Kudo M; Kitai S; El-Shamy A; Hotta H; Hayashi Y
    Digestion; 2009; 79(1):36-9. PubMed ID: 19246919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid disorders and occurrence of nonorgan-specific autoantibodies (NOSA) in patients with chronic hepatitis C before and during antiviral induction therapy with consensus interferon (interferon alfacon-1).
    Hass HG; Klein R; Nehls O; Kaiser S
    J Clin Gastroenterol; 2009; 43(5):470-6. PubMed ID: 19247202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of chronic hepatitis C in HIV-infected patients.
    Soriano V; Rodríguez-Rosado R; García-Samaniego J
    AIDS; 1999 Apr; 13(5):539-46. PubMed ID: 10203378
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of chronic hepatitis C therapy with interferon alpha (IFN-alpha) in Slovenia.
    Brinovec V; Lesnicar G; Maticic M; Meglic-Volkar J; Poljak M; Seme K; Ferlan-Marolt V
    Hepatogastroenterology; 2002; 49(47):1320-5. PubMed ID: 12239935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C.
    Borgia G; Reynaud L; Gentile I; Cerini R; Ciampi R; Dello Russo M; Piazza M
    J Interferon Cytokine Res; 2001 Jul; 21(7):469-70. PubMed ID: 11506739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy.
    Saitta C; Pontisso P; Brunetto MR; Fargion S; Gaeta GB; Niro GA; Picciotto A; Smedile A; Squadrito G; Raimondo G
    Antivir Ther; 2006; 11(7):931-4. PubMed ID: 17302256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.